Salaka Pharma Care Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.43 M
- Company Age 22 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 76.91%
- Profit Growth 13.60%
- Ebitda 19.57%
- Net Worth -48.32%
- Total Assets -71.35%
About Salaka Pharma Care
Salaka Pharma Care Private Limited (SPCPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 September 2002 and has a history of 22 years and five months. Its registered office is in Aligarh, Uttar Pradesh, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.43 M, as per Ministry of Corporate Affairs (MCA) records.
Ravindra Varshney, Pavan Varshney, and Mayank Varshney serve as directors at the Company.
Company Details
- Location
Aligarh, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233UP2002PTC026933
- Company No.
026933
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Sep 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Salaka Pharma Care?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pavan Varshney  | Managing Director | 17-Sep-2002 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravindra Varshney | Director | 17-Sep-2002 | Current |
| Mayank Varshney | Additional Director | 15-Jul-2019 | Current |
Financial Performance of Salaka Pharma Care.
Salaka Pharma Care Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 76.91% increase. The company also saw a substantial improvement in profitability, with a 13.6% increase in profit. The company's net worth observed a substantial decline by a decrease of 48.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Salaka Pharma Care?
In 2017, Salaka Pharma Care had a promoter holding of 83.72% and a public holding of 16.28%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Swastik Metalloy Castings Private LimitedPavan Varshney is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Salaka Pharma Care?
Unlock and access historical data on people associated with Salaka Pharma Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Salaka Pharma Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Salaka Pharma Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
